Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in a child infected with human immunodeficiency virus-Reference-Cited by-同舟云学术

Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in a child infected with human immunodeficiency virus

Published:1992-03 Issue:3 Volume:120 Page:483-486
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Butler Karina M.,Smet Marc D. De,Husson Robert N.,Mueller Brigitta,Manjunath Kallanna,Montrella Karen,Lovato Gayle,Jarosinski Paul,Nussenblatt Robert B.,Pizzo Philip A.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference17 articles.

1. The diagnosis of cytomegalovirus retinitis;Bloom;Ann Intern Med,1988

2. Treatment of cytomegalovirus retinopathy with ganciclovir;Holland;Ophthalmology,1987

3. Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis;Jacobson;J Med Virol,1988

4. Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients;Buhles;Rev Infect Dis,1988

5. Foscarnet therapy of cytomegalovirus retinitis in AIDS;Fanning;J Acquir Immun Defic Syndr,1990

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYTOMEGALOVIRUS;Feigin and Cherry's Textbook of Pediatric Infectious Diseases;2009

2. Treating Opportunistic Infections among HIV-Exposed and Infected Children: Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America;Clinical Infectious Diseases;2005-02-01

3. Cytomegalovirus and the Eye;Uveitis and Immunological Disorders;2005

4. Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus;Antiviral Research;2002-10

5. Plant-Derived and Semi-Synthetic Calanolide Compounds with in Vitro Activity against Both Human Immunodeficiency Virus Type 1 and Human Cytomegalovirus;Antiviral Chemistry and Chemotherapy;2000-02